Venetoclax in Patients With MDS or AML in Relapse After AHSCT
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
Active, not recruiting · NCT05226455 · Registry updated 2026-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax in Patients With MDS or AML in Relapse After AHSCT | acute myeloid leukemia, myelodysplastic syndrome | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-12 | NCT05226455 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| Groupe Francophone des Myelodysplasies | 10 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Henri Becquerel | Rouen | France | 59 |
| Centre Hospitalier Lyon-Sud | Pierre-Bénite | France | 8 |
| CHU d'Angers | Angers | France | 25 |
| CHU de Grenoble | Grenoble | France | 22 |
| CHU de Haut-Lévèque | Pessac | France | 2 |
| CHU Hôtel Dieu | Nantes | France | 5 |
| Hôpital Dupuytren | Limoges | France | 1 |
| Hôpital l'Archet I | Nice | France | 1 |
| Hôpital Saint Louis | Paris | France | 22 |
| Hôpital Saint-Eloi | Montpellier | France | 2 |
| IUCT Oncopole | Toulouse | France | 12 |